Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

Clinical trial NCT07071636 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07071636
Sponsor: Shenzhen Third People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatotic Liver Disease Chronic Hepatitis B

Start date: 2025-08-15
Primary completion: 2027-12-31
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.